Clinical trials
Inflammation trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coordinación de Investigación en Salud, Mexico | 5 |
| Novo Nordisk A/S | 3 |
| University of Guadalajara | 2 |
| Anahuac University | 1 |
| Bernardo Rodríguez Iturbe | 1 |
| Brenda Sarahí Beristain Lujano | 1 |
| Centenario Hospital Miguel Hidalgo | 1 |
| Elisa Barron-Cabrera | 1 |
| Federal University of São Paulo | 1 |
| Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 38 |
| Obesity | 5 |
| Renal Insufficiency, Chronic | 4 |
| Arthritis, Rheumatoid | 3 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Hypertension | 3 |
| Overweight | 3 |
| Kidney Failure, Chronic | 2 |
| Arthritis | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.